Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2025 1.308B
December 31, 2024
September 30, 2024 1.229B
June 30, 2024 1.271B
March 31, 2024 1.428B
December 31, 2023 1.334B
September 30, 2023 1.210B
June 30, 2023 1.157B
March 31, 2023 1.050B
December 31, 2022 980.93M
September 30, 2022 926.47M
June 30, 2022 883.90M
March 31, 2022 905.83M
December 31, 2021 846.04M
September 30, 2021 817.39M
June 30, 2021 808.86M
March 31, 2021 756.07M
December 31, 2020 792.60M
September 30, 2020 681.38M
June 30, 2020 629.00M
March 31, 2020 601.41M
December 31, 2019 737.59M
September 30, 2019 675.77M
June 30, 2019 676.72M
March 31, 2019 649.41M
Date Value
December 31, 2018 634.87M
September 30, 2018 647.39M
June 30, 2018 597.55M
March 31, 2018 622.27M
December 31, 2017 570.09M
September 30, 2017 595.52M
June 30, 2017 580.70M
March 31, 2017 540.68M
December 31, 2016 486.68M
September 30, 2016 491.57M
June 30, 2016 502.76M
March 31, 2016 535.01M
December 31, 2015 518.77M
September 30, 2015 505.25M
June 30, 2015 532.15M
March 31, 2015 533.96M
December 31, 2014 544.37M
September 30, 2014 574.76M
June 30, 2014 577.37M
March 31, 2014 556.07M
December 31, 2013 543.19M
September 30, 2013 512.09M
June 30, 2013 500.02M
March 31, 2013 523.31M
December 31, 2012 477.52M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 196.38M
Integrated BioPharma, Inc. 17.67M
Wal-Mart de México SAB de CV 13.66B
Skinvisible, Inc. -10.79M
Kimberly-Clark de México SAB de CV 228.46M